INMB
INmune Bio Inc.
Company Overview
| Mkt Cap | $50.51M | Price | $1.83 |
| Volume | 506.72K | Change | +5.78% |
| P/E Ratio | -1.2 | Open | $1.75 |
| Revenue | $14.0K | Prev Close | $1.73 |
| Net Income | $-42.1M | 52W Range | $1.71 - $11.64 |
| Div Yield | N/A | Target | $12.67 |
| Overall | 46 | Value | 60 |
| Quality | 42 | Technical | 36 |
No chart data available
Stock Overview
Updated DailyINmune Bio Inc. (INMB) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.83 with a market capitalization of $50.51 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows INMB with a volume of 507K shares. The stock opened up 1.16% from yesterday's close of $1.73. Current analyst estimates project earnings of $-1.34 per share for this year, with next year targeting $-1.29.
INMB demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for INMB include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 592.3%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INMB | $1.83 | +5.8% | 506.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |